As a manufacturer of anti-infective medication, we consider it our responsibility to educate patients, healthcare professionals and policymakers, particularly in Jordan, about the rising threat of anti-microbial resistance (AMR) and to encourage the responsible use of our products.
Our initiatives to tackle the threat of AMR in the MENA region include:
- Sponsoring the ‘Rational use of antibiotics and antimicrobial stewardship summit’ in Jordan in 2018. The aims of the summit were to share with regional policymakers and industry peers the developing role of governments in curbing AMR, opportunities for collaboration to promote national awareness, and the role of conventional and novel diagnostic and therapeutic techniques to confront AMR.
- Working alongside the Jordan Food and Drug Administration (JFDA), the Ministry of Health and the Pharmaceutical Association of Jordan, we organised and sponsored a new initiative, the ‘National action plan for containment of antimicrobial resistance’, which aims to develop local solutions to manage AMR in Jordan.